6/1/24 |
Eli Lilly (LLY) |
Olomorasib for Non-Small Cell Lung Cancer (NSCLC) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
6/1/24 |
Arcus (RCUS) |
Zimberelimab for Gastric Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
6/1/24 |
Bristol Myers Squibb (BMY) |
Krazati for Non-Small Cell Lung Cancer (NSCLC) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
6/1/24 |
AstraZeneca (AZN) |
Ceralasertib for Ovarian Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
6/1/24 |
Sinocelltech |
SCT-510A for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) |
Subscribers Only |
Subscribers Only |
Subscribers Only |